







For those familiar with Piracetam.. Aniracetam is another nootropic that is supposed to be more effective at lower dosages, and they're correct - it's effective. I took 2.6g of it about 3 hours...
Lamictal and Estrogen
Heading into my late 40s and am perimenopausal, so my gp suggested a partial estrogen supplement (raloxifene). Because I was so desperate to…
Buy Nootropics From These Safe & Trusted Suppliers
Here’s where I buy safe, toxin-free, and powerful nootropics for great prices. These are the sources I buy from and trust. Personally vetted.
A Comparison Of 4 Racetams and Their Risks - SelfHacked
Piracetam was first, but what about other racetam “smart drugs”? Read on as we compare the risks of four closely related nootropics.

Magnesium and the Brain: The Original Chill Pill
Magnesium is an old home remedy for all that ails you, including "anxiety, apathy, depression, headaches, insecurity, irritability, restlessness, talkativeness, and sulkiness."

Potential New Cure Found For Baldness - Slashdot
A potential new cure for baldness has been discovered using a drug originally intended to treat osteoporosis. BBC reports: Researchers found the drug had a dramatic effect on hair follicles in the lab, stimulating them to grow. It contains a compound which targets a protein that acts as a brake on h...

Lamotrigine in the maintenance treatment of bipolar disorder
Lamotrigine as a treatment for prevention of recurrence of bipolar disorder, Review question, To investigate the clinical effectiveness (benefits and harms) of lamotrigine for maintenance therapy of bipolar disorder in comparison with placebo, combination therapy or existing drugs (e.g. lithium, olanzapine)., Background, Lamotrigine is approved for the maintenance treatment (treatment for prevention of recurrence) of bipolar disorder. It could be a viable and effective treatment strategy for the maintenance of bipolar disorder, where it demonstrated a lower risk of recurrence than placebo. In addition, it has been reported to be as effective as lithium. Therefore, we performed a systematic review to investigate the efficacy and safety of lamotrigine in the maintenance treatment (treatment for prevention of recurrence) of bipolar disorder., Key findings, The evidence is current to May 2021. We included 11 studies in this review with a total 2314 participants. 1146 participants were assigned to lamotrigine, and 1168 participants were assigned to control intervention (869 received placebo and 299 received lithium)., Our review identified the following., Lamotrigine versus placebo, Benefits: lamotrigine was found to be superior over placebo in the following outcomes., 1) Reduced the rate of recurrence of manic symptoms , 2) Suppressed depressive symptoms, 3) Less need for additional therapeutic agents for the recurrence of all symptoms, 4) Reduction in the withdrawal rate due to any causes six months or more after the initiating of intervention, Harms: adverse‐event profile of lamotrigine was similar to that of placebo., Lamotrigine versus lithium, Benefits: lamotrigine was as effective as lithium, except for the recurrence of manic symptoms, for which the rate was higher in people who received lamotrigine than people treated with lithium., Harms: the rate of adverse events associated with lamotrigine was lower than that of lithium., Certainty of the evidence, We assessed the certainty of our included evidence to be very low to moderate. This is because majority of the included trials did not describe how treatment allocation was concealed. Given that we were unable to identify high‐confidence evidence the overall findings of this systematic review should be interpreted carefully., Conclusions, Lamotrigine may be superior to placebo in efficacy and may be comparable in safety. And then, lamotrigine was as effective as lithium except for its recurrence rate of mania, and was superior to lithium in terms of safety. Future studies in this field with robust methods and transparent reporting are needed to confirm our results and to fully answer our pre‐specified review question.

Combination of raloxifene, aspirin and estrogen as novel paradigm of hormone replacement therapy in rabbit model of menopause
To assess a novel hormone replacement therapy (HRT) paradigm using raloxifene, aspirin combined with estrogen in rabbit model of menopause.

The Mystery in the Medicine Cabinet
Acetaminophen, ibuprofen, and what doctors probably want you to know.

OTC nasal spray reduces the risk of COVID-19 infection by 70%
The active ingredient in a common over-the-counter allergy spray may do more than ease hay fever symptoms. A new clinical trial found azelastine cut COVID-19 infections by 70%, hinting at a cheap, accessible way to add protection alongside vaccines.

E + Raloxifene 5 week update
20 votes, 13 comments. 135K subscribers in the TransDIY community. Questions and resources related to Hormone Replacement Therapy (HRT), for…
Supplements for MCAS and Histamine Intolerance | The EDS Clinic
Managing Mast Cell Activation Syndrome (MCAS) and histamine intolerance involves a combination of medications, lifestyle changes, and dietary supplements. Supplements, in particular, can play a critical role in helping to reduce symptoms by stabilizing mast cells, reducing inflammation, and improving overall health.
Closest Thing to a Wonder Drug? Try Exercise (Published 2016)
If the effects of exercise could be put in a pill and prescribed, it would be rightly hailed as an almost miraculous cure. So get off the couch.

Ibuprofen May Not Be As Safe As You Think
Ibuprofen and naproxen have long been thought as the better pain relievers, but a study comparing them to celecoxib found surprising results

Israeli study: Food supplement could lower Prozac dosage, reduce side effects
Taken alongside drug, plant-derived substance shown to reduce dose needed to calm mice; researchers hope this could translate to humans

New Ketamine study 🧪. Abstract: ✅Ketamine "tablets were effective, safe & well tolerated" Actual results: ❌At primary endpoint of 13 weeks, 0 of 4 ketamine groups outperformed placebo /re remission ❌At 13 weeks, only 1 of 4 outperformed placebo /re response, with a beautiful p-value of 0.046 🤪
Extended-release ketamine tablets for treatment-resistant depression: a randomized placebo-controlled phase 2 trial - Nature Medicine
www.nature.com